Construction of a TFs-miRNA-mRNA network related to idiopathic pulmonary fibrosis

Minhong Su1, Junfang Liu1, Xiping Wu1

  • 1Department of Respiratory and Critical Care Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, China.

Abstract

Insights

This study constructed a novel transcription factor-microRNA-messenger RNA network for idiopathic pulmonary fibrosis (IPF). Specific genes identified in this network may serve as crucial biomarkers for IPF diagnosis and treatment.

Area of Science:

  • Molecular Biology
  • Genomics
  • Systems Biology

Background:

  • The interplay between transcription factors (TFs), microRNAs (miRNAs), and messenger RNAs (mRNAs) is critical in disease pathogenesis.
  • The specific molecular network governing idiopathic pulmonary fibrosis (IPF) remains incompletely understood.

Purpose of the Study:

  • To elucidate the TFs-miRNA-mRNA regulatory network implicated in IPF.
  • To identify potential molecular biomarkers for IPF diagnosis and therapeutic intervention.

Main Methods:

  • Utilized Gene Expression Omnibus (GEO) datasets (GSE110147, GSE53845, GSE13316) for differential gene and miRNA expression analysis.
  • Applied Weighted Gene Co-expression Network Analysis (WGCNA), Gene Set Enrichment Analysis (GSEA), Gene Ontology (GO), and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses.
  • Constructed and functionally evaluated a TFs-miRNA-mRNA network, with key TF expression validated via quantitative real-time polymerase chain reaction (qRT-PCR).

Main Results:

  • Identified 53 differentially expressed miRNAs (DEMs) and 2,630 differentially expressed genes (DEGs).
  • Constructed a regulatory network comprising 25 TFs, 11 miRNAs, and 60 mRNAs, significantly associated with cell cycle and PI3K-Akt signaling pathways.
  • Validated differential expression of nine key TFs (e.g., ARNTL, EZH2, BCL6) in response to TGF-β1 stimulation.

Conclusions:

  • A novel TFs-miRNA-mRNA network provides new insights into IPF molecular mechanisms.
  • Identified TFs, including ARNTL, TRIM28, EZH2, BCOR, ASXL1, BCL6, BHLHE40, FOXA1, and EGR1, as potential diagnostic and therapeutic biomarkers for IPF.

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
320
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.9K